Minnesota
July 2, 2026
A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can significantly change how physicians diagnose and treat pulmonary fibrosis — in some cases even redirecting the course of care.
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community